Blackwell, L.S.; Wali, B.; Xiang, Y.; Alawieh, A.; Sayeed, I.; Reisner, A.
Prognostic Value of Plasma Biomarkers S100B and Osteopontin in Pediatric TBI: A Prospective Analysis Evaluating Acute and 6-Month Outcomes after Mild to Severe TBI. Biomedicines 2023, 11, 2167.
https://doi.org/10.3390/biomedicines11082167
AMA Style
Blackwell LS, Wali B, Xiang Y, Alawieh A, Sayeed I, Reisner A.
Prognostic Value of Plasma Biomarkers S100B and Osteopontin in Pediatric TBI: A Prospective Analysis Evaluating Acute and 6-Month Outcomes after Mild to Severe TBI. Biomedicines. 2023; 11(8):2167.
https://doi.org/10.3390/biomedicines11082167
Chicago/Turabian Style
Blackwell, Laura S., Bushra Wali, Yijin Xiang, Ali Alawieh, Iqbal Sayeed, and Andrew Reisner.
2023. "Prognostic Value of Plasma Biomarkers S100B and Osteopontin in Pediatric TBI: A Prospective Analysis Evaluating Acute and 6-Month Outcomes after Mild to Severe TBI" Biomedicines 11, no. 8: 2167.
https://doi.org/10.3390/biomedicines11082167
APA Style
Blackwell, L. S., Wali, B., Xiang, Y., Alawieh, A., Sayeed, I., & Reisner, A.
(2023). Prognostic Value of Plasma Biomarkers S100B and Osteopontin in Pediatric TBI: A Prospective Analysis Evaluating Acute and 6-Month Outcomes after Mild to Severe TBI. Biomedicines, 11(8), 2167.
https://doi.org/10.3390/biomedicines11082167